Načítá se...
Genetic variations associated with gemcitabine treatment outcome in pancreatic cancer
BACKGROUND: Pancreatic cancer is a rapidly fatal disease with gemcitabine remaining the first-line therapy. We performed a genotype–phenotype association study to identify biomarkers for predicting gemcitabine treatment outcome. MATERIALS AND METHODS: We selected the top 200 single nucleotide polymo...
Uloženo v:
| Vydáno v: | Pharmacogenet Genomics |
|---|---|
| Hlavní autoři: | , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Lippincott Williams & Wilkins
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5083195/ https://ncbi.nlm.nih.gov/pubmed/27749787 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/FPC.0000000000000241 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|